نتایج جستجو برای: allogeneic stem cell transplantation

تعداد نتایج: 1894343  

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran roshanak derakhshandeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran arash jalali hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ali jafarpour hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amirali hamidieh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

introductio: hematopoietic stem cell transplants (hsct) are considered as treatment options for patients with solid tumors. transplant numbers have changed significantly over the last decade. we have done autologous and allogeneic hsct for treatment of solid tumor patients in our center. methods: in order to show the transplant effect on solid tumor treatment, we collected data from 71 patients...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran kamran alimogaddam hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran amirali hamidieh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran seyed asadollah mousavi hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: this review reports the current results of hematopoietic stem cell transplantation (hsct) in patients who had received transplantation in the hematology-oncology and sct research center, tehran, iran. methods: in iran, from 1991 through 2010, a total of 3170 hematopoietic stem cell transplantation have been carried out. the male/female patient ratio was 1909/1261 with a median age...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad faizan zahid medical college, the aga khan university, karachi, pakistan. natasha ali departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan. mohammad usman shaikh departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan. salman naseem adil departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan.

introduction: allogeneic hematopoietic stem cell transplantation is a potentially curative treatment modality for hematological malignancies. we evaluated the outcome of patients suffering from hematological malignancies, including acute leukemias, chronic myeloid leukemia and myelodysplastic syndrome after allogeneic transplantation. methods: all patients having hematological malignancies with...

Journal: :acta medica iranica 0
a. ghavamzadeh m. iravani m. jahani b. bahar a. mousavi s. gholibeikian

in this center, from 1991 to 2002, 89 chronic myelogenous leukemic (cml) patients, age ranging between 8-48 years with a median age of 29, underwent hematopoietic stem cell transplantation. eighty-eight patients were in the first chronic phase of disease. twenty-three patients received bone marrow transplantation (bmt) and 66 patients received peripheral blood stem cell transplantations (pbsct)...

Journal: :international journal of hematology-oncology and stem cell research 0
soudabeh hosseini department of hematology and blood transfusion, school of allied medical sciences, iran university of medical sciences, tehran, iran shahla ansari hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran parvaneh vosough hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran gholamreza bahoush hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran morteza shamsizadeh department of medical-surgical nursing, school of nursing and midwifery, hamadan university of medical sciences, hamadan, iran mitra mehrazma department of pathology, iran university of medical sciences, tehran, iran

isolated extramedullary relapse of chronic myelogenous leukemia (cml) after allogeneic stem cell transplant is rare. there is a case report of a child who developed a granulocytic sarcoma of the maxillary and sphenoid sinuses and lumbosacral spinal cord mass 18 months after allogeneic bone marrow transplant for cml. he was presented with per orbital edema and neurological deficit of lower extre...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: acute myelogenous leukemia (aml) is a clonal  malignant disease of hematopoietic tissue. the early use of  hematopoietic stem cell transplantation (hsct) for aml was for patients with advanced stages of disease, usually while in relapse, in second or subsequent remission, or with resistant disease. patients and methods: from march 1991 until february 2008, 356(65%) registered allo...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: the traditional goal of the treatment of acute myelogenous leukemia is to produce and maintain a complete remission (cr).the difference in survival time was entirely attributable to the duration of time spent in cr .in this study, the outcome of aml patients with allogeneic hsct in cr1 versus other than cr1 was compared. patients and methods: since march 1991 until november 2008, ...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran mohammad jahani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran seyed asad-o-allah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran

hematology- oncology and stem cell transplantation research center related to tehran university of medical sciences located in shariati hospital. these center activities have started in 1991 in order to help needful patients and augment new data to reach new aspects of therapeutic trials. also it is one of the greatest stem cell transplantation centers in world and is the second center in the w...

Journal: :international journal of hematology-oncology and stem cell research 0
kamran alimoghaddam hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran mohamad jahani hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran arash jalali hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran hoda jorjani hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran massoud iravani hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran

introduction: acute promyelocytic leukemia treatment revolutionized by new tretamnets. currently number of patinets who undergoe hematopoietic stem cell transplantation decrased so experience with this modality is limited. here we report our experience with stem cell transplantation in acute promyelocytic leukemia patients. design and setting: retrospective, single center methods: between year ...

ژورنال: یافته 2012
شاهسوار, فرهاد, آذرگون, علیرضا , سابوته, توماج , علی‌مقدم, کامران , نظرزاده, سارا ,

Background : Graft versus host disease (GVHD) is among major complications of allogeneic hematopoietic stem cells transplantation, and also is an important factor affecting the outcome of transplantation. An increased incidence of GVHD has been suggested following allogeneic peripheral blood stem cells (PBSC) transplantation, however, how this affects survival is not yet well clear. In this stu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید